Interobserver agreement in scoring HER2-negative and HER2-low immunohistochemistry in breast cancer: Reasons for discordance and impact of a single training session
Poor concordance on HER2-0 vs HER2-L and lack of improvement after a training session likely suggest ineffective HER2 IHC expression range in HER2 low spectrum.
Authors
- Evi Abada (ORCID: https://orcid.org/0000-0001-5061-2687)
- Yun-An Tseng
- Chih‐Wei Sung (ORCID: https://orcid.org/0000-0003-3312-2752)
- Kamaljeet Singh (ORCID: https://orcid.org/0000-0002-2506-5703)
- Steffanie Charlyne Tamayo (ORCID: https://orcid.org/0000-0003-2935-4374)
- Katrine Bagge Hansen (ORCID: https://orcid.org/0000-0002-2587-5589)
- Shivali Marketkar (ORCID: https://orcid.org/0000-0002-6894-0168)
- M. Ruhul Quddus (ORCID: https://orcid.org/0000-0002-1371-9095)
- Linda C. Hanley
Institutions
- Brown University (US)
- Women & Infants Hospital of Rhode Island (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- American Journal of Clinical Pathology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1093/ajcp/aqaf043
- Citations
- 4
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 4.18